BioNTech SE (BNTX)
NASDAQ·Healthcare·Biotechnology
$101.81
-0.25%
Mkt Cap $24.56B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $902.33M | $1.07B | +18.11% | -$0.22 | -$0.38 | -72.73% | — | — |
| Q4 2025 Nov 3, 2025 | $843.68M | $1.78B | +110.86% | -$1.12 | -$0.14 | +87.47% | — | — |
| Q3 2025 Aug 4, 2025 | $177.80M | $307.08M | +72.71% | -$2.69 | -$1.82 | +32.32% | — | — |
| Q2 2025 May 5, 2025 | $215.12M | $200.39M | -6.85% | -$2.48 | -$1.82 | +26.55% | — | — |
| Q1 2025 Mar 10, 2025 | $1.18B | $1.23B | +4.36% | $0.46 | $1.15 | +148.70% | — | — |
| Q4 2024 Nov 4, 2024 | $572.38M | $1.39B | +142.92% | -$1.74 | $0.89 | +151.11% | — | — |
| Q3 2024 Aug 5, 2024 | $145.36M | $138.38M | -4.80% | -$2.19 | -$3.62 | -65.18% | — | — |
| Q2 2024 May 6, 2024 | $479.46M | $201.53M | -57.97% | -$1.34 | -$1.42 | -5.85% | — | — |
| Q1 2024 Mar 20, 2024 | $2.03B | $1.63B | -19.78% | $2.62 | $2.05 | -21.76% | — | — |
| Q4 2023 Nov 6, 2023 | $899.06M | $944.40M | +5.04% | -$0.62 | $0.73 | +217.02% | — | — |
| Q3 2023 Aug 7, 2023 | $685.12M | $182.95M | -73.30% | -$0.91 | -$0.86 | +5.40% | — | — |
| Q2 2023 May 8, 2023 | $1.15B | $1.39B | +20.70% | $0.29 | $2.20 | +665.75% | — | — |
| Q1 2023 Mar 27, 2023 | $3.91B | $4.61B | +17.84% | $8.32 | $9.46 | +13.70% | — | — |
| Q4 2022 Nov 7, 2022 | $2.02B | $3.38B | +67.02% | $3.35 | $7.04 | +110.15% | — | — |
| Q3 2022 Aug 8, 2022 | $4.07B | $3.34B | -17.86% | $7.42 | $7.31 | -1.48% | — | — |
| Q2 2022 May 9, 2022 | $4.80B | $7.05B | +46.94% | $10.14 | $15.98 | +57.59% | — | — |
| Q1 2022 Mar 30, 2022 | $4.45B | $6.27B | +40.83% | $8.46 | $13.93 | +64.66% | — | — |
| Q4 2021 Nov 9, 2021 | $5.68B | $7.07B | +24.40% | $11.79 | $14.56 | +23.49% | — | — |
| Q3 2021 Aug 9, 2021 | $3.26B | $6.30B | +93.07% | $8.35 | $12.98 | +55.45% | — | — |
| Q2 2021 May 10, 2021 | $1.96B | $2.41B | +23.05% | $4.31 | $5.29 | +22.74% | — | — |